CleanUP IPF for the Pulmonary Trials Cooperative
- Status
- TERMINATED
- Phase
- PHASE3
Clinical Trials Related to Idiopathic Pulmonary Fibrosis
Related studies linked through entity extraction aliases.
Pulmonary Fibrosis Biomarker Cohort - a Prospective Cohort of Incident Patients With IPF
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- N/A
Clinical Efficacy and Safety of Autologous Lung Stem Cell Transplantation in Patients With Idiopathic Pulmonary Fibrosis
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Clinical Study of ART-123 for the Treatment of Acute Exacerbation of Idiopathic Pulmonary Fibrosis
- Status
- COMPLETED
- Phase
- PHASE3
Study to Assess Safety, Tolerability, Pharmacokinetic and Pharmacodynamic Properties of GLPG1690 in Subjects With Idiopathic Pulmonary Fibrosis (IPF)
- Status
- COMPLETED
- Phase
- PHASE2
A Study to Assess the Safety and Tolerability of N-Acetylcysteine When Administered With Pirfenidone to Participants With Idiopathic Pulmonary Fibrosis (IPF)
- Status
- COMPLETED
- Phase
- PHASE2
Evaluation of Long-Term Safety of Pirfenidone (Esbriet) in Participants With Idiopathic Pulmonary Fibrosis (IPF)
- Status
- COMPLETED
- Phase
- N/A
A 2-Part, Phase 2 Open-label and Crossover Study of Belumosudil for Treatment of Idiopathic Pulmonary Fibrosis
- Status
- COMPLETED
- Phase
- PHASE2
A Study of Oral Vismodegib in Combination With Pirfenidone in Participants With Idiopathic Pulmonary Fibrosis
- Status
- COMPLETED
- Phase
- PHASE1
Validation of the Risk Stratification Score in Idiopathic Pulmonary Fibrosis
- Status
- COMPLETED
- Phase
- N/A
Exhaled Breath Condensate Biomarkers and Cough in IPF
- Status
- COMPLETED
- Phase
- N/A
Clinical Progression of Mild to Moderate Idiopathic Pulmonary Fibrosis (IPF) Under a Therapy With Esbriet® (Pirfenidone)
- Status
- COMPLETED
- Phase
- N/A
First Time in Human (FTIH) Study of GSK3008348 in Healthy Volunteers and Idiopathic Pulmonary Fibrosis Patients
- Status
- COMPLETED
- Phase
- PHASE1
All-Case Surveillance of Ofev in Patients With IPF in Japan
- Status
- COMPLETED
- Phase
- N/A
A Study to Compare the Amount of Nintedanib and Pirfenidone in the Blood When Nintedanib and Pirfenidone Are Given Separately or in Combination
- Status
- COMPLETED
- Phase
- PHASE4
Home-Based Pulmonary Rehab for Patients With Pulmonary Fibrosis
- Status
- COMPLETED
- Phase
- NA
Safety and Tolerability Study of Pirfenidone in Combination With Nintedanib in Participants With Idiopathic Pulmonary Fibrosis (IPF)
- Status
- COMPLETED
- Phase
- PHASE4
Safety and Efficacy of Allogeneic Mesenchymal Stem Cells in Patients With Rapidly Progressive Interstitial Lung Disease
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Safety, Tolerability and PK of Nintedanib in Combination With Pirfenidone in IPF
- Status
- COMPLETED
- Phase
- PHASE4
Observational Study to Evaluate Disease Course and Outcomes in Patients Treated With Esbriet (Pirfenidone) for Idiopathic Pulmonary Fibrosis (IPF) in Canada
- Status
- COMPLETED
- Phase
- N/A